Condition: Gastroparesis · Gastroparesis Nondiabetic · Gastroparesis Due to Diabetes Mellitus · Sponsor: Enterra Medical, Inc.
The purpose of this research study is to evaluate if an enhanced Enterra device programming strategy will improve symptoms associated with gastroparesis, improve symptoms in a faster amount of time, and improve quality of life measures. Participants in this study will be evaluated for study entry criteria, have an Enterra Therapy System implanted, and be randomly assigned to one of two programming strategies. Participants will answer daily questions about their gastroparesis symptoms on an application with their phone/tablet. Participants will answer quality of life questionnaires about their gastroparesis symptoms at monthly study visits. Participants will be involved in the study for up to six months after treatment assignment. Programming parameters in the study are within currently approved labeling.
This description comes directly from the study's public registry record.
Timothy McAllister · 855-768-3772 · clinicalresearch@enterramedical.com
Jason Hamann, PhD · 855-768-3772 · clinicalresearch@enterramedical.com
Always discuss trial participation with your own doctor first.
| University of South Florida | Tampa, Florida, United States | Recruiting |
| University of Louisville | Louisville, Kentucky, United States | Recruiting |
| Henry Ford Health System | Detroit, Michigan, United States | Recruiting |
| Washington University | St Louis, Missouri, United States | Recruiting |
| Foundation for Surgical Innovation | Portland, Oregon, United States | Recruiting |
| Benaroya Research Institute at Virginia Mason | Seattle, Washington, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06560307